Chris Torrance

1.3k citations
6 papers · 969 indexed · 1 hit paper · h-index 4
Topics
Cancer Genomics and Diagnostics (2 papers)Cancer-related Molecular Pathways (2 papers)Glycosylation and Glycoproteins Research (1 paper)
Partner nations
ItalySpainUnited States

In The Last Decade

Chris Torrance

6 papers receiving 949 citations

Hit Papers

Disruption of p53 in human cancer cells alters the respon...19992026200820171999250500750

Peers

Chris Torrance
Comparison fields: 5 of 78
  • Molecular Biology 651
  • Oncology 624
  • Cancer Research 235
  • Biotechnology 117
  • Pathology and Forensic Medicine 114
Replace Kazunori Otsuka with:
Kazunori Otsuka Japan
Rohit Chugh United States
I Bae United States
María José Muñoz-Alonso Spain
Alla Polotskaia United States
Sanghyun Lee South Korea
M V Blagosklonny United States
Nayoung Jun South Korea
Alexei V. Salnikov Germany
Elisabeth Hedström Sweden
Chris Torrance relative to Kazunori Otsuka Japan Kazunori Otsuka's profile →
Citations per field
00.5×1.5×
Kazunori Otsuka · 1×
Citations per year

Countries citing papers authored by Chris Torrance

Since Specialization
Citations

This map shows the geographic impact of Chris Torrance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Torrance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Torrance more than expected).

Fields of papers citing papers by Chris Torrance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chris Torrance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Torrance. The network helps show where Chris Torrance may publish in the future.

Co-authorship network of co-authors of Chris Torrance

This figure shows the co-authorship network connecting the top 25 collaborators of Chris Torrance. A scholar is included among the top collaborators of Chris Torrance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chris Torrance. Chris Torrance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

About Chris Torrance

Chris Torrance is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 6 papers that have together received 969 indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (2 papers), Cancer-related Molecular Pathways (2 papers) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Oncology (624 citations), Cancer Research (235 citations) and Biotechnology (117 citations). Chris Torrance has collaborated with scholars based in Italy, Spain and United States. Frequent co-authors include Todd Waldman, Kenneth W. Kinzler, Jerry Williams, Yonggang Zhang, Larry E. Dillehay, Fred Bunz, Bert Vogelstein, Paul M. Hwang, Christoph Lengauer and Jane Zhao. Their work appears in journals such as Journal of Clinical Investigation, PLoS ONE and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026